Gilead Sciences (GILD) Target Price Upped to $85 at Needham & Company Post Q3

October 30, 2013 12:26 PM

Needham & Company analyst Alan Carr, Ph.D. reiterated a Buy and raised his price target on Gilead Sciences (NASDAQ: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found